Progress in the development and use of antiviral drugs and interferon: report of a WHO Scientific Group /

QR Code

Progress in the development and use of antiviral drugs and interferon: report of a WHO Scientific Group /

Saved in:

Bibliographic Details
Main Author:	WHO Scientific Group
Corporate Author:	World Health Organization
Format:	Book
Published:	Geneva : World Health Organization, 1987.
Series:	Technical report series (World Health Organization);
Subjects:	Interferon Drugs
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)

Interferons : an example of communication /
by: Sanders, F. Kingsley (Frank Kingsley)
Published: (1981)

Interferon Lambda: The Next Frontier in Antiviral Therapy?
by: Sofia Chronopoulou, et al.
Published: (2025-05-01)

Investigation of the antiviral activity of the recombinant human interferon lambda 1 in human conjunctiva cell culture
by: N. A. Kikhtenko, et al.
Published: (2021-10-01)

Research on the menopause in the 1990s : report of a WHO Scientific Group /
by: WHO Scientific Group
Published: (1996)

ADMINISTRATION CRITERIA FOR INTERFERON-BASED DRUGS AND ITS INDUCERS IN ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: E. G. Golovacheva, et al.
Published: (2014-07-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Modern Russian Etiotropic Antiinfluenza Drugs
by: F. I. Ershov, et al.
Published: (2020-05-01)

Interferon status at the women with recurrent genital herpes in combined liposomal RNA treatment
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)

DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS
by: E. V. Mityushova, et al.
Published: (2019-01-01)

The role of cytokines and interferons during pregnancy
by: T. Е. Belokrinitskaya, et al.
Published: (2024-09-01)

Antiviral properties of composition drugs based on double-stranded RNA and human interferon alpha-2b
by: S. G. Gamaley, et al.
Published: (2025-02-01)

Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01)

Editorial: Modulation of pro-inflammatory signaling by interferons
by: René Huber, et al.
Published: (2025-07-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)
by: E. L. Nasonov, et al.
Published: (2021-10-01)

EFFICACY OF INTRAPERITONEAL INTERFERON-α ADMINISTRATION FOR TREATMENT OF ENDOMETRIOSIS IN RATS
by: R. V. Pavlov, et al.
Published: (2014-07-01)

ROLE OF INTERFERONS IN REGULATION OF OSTOGENIC AND OSTEORESORPTIVE PROCESSES
by: L. A. Dmitrieva, et al.
Published: (2012-09-01)

Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain
by: Ti-Chuan Chiu, et al.
Published: (2025-06-01)

Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report)
by: A. A. Baranov, et al.
Published: (2024-06-01)

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups
by: K. V. Kozlov, et al.
Published: (2024-04-01)

Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
by: T. M. Reshetnyak, et al.
Published: (2023-12-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
by: A. A. Shuldyakov, et al.
Published: (2020-05-01)

Results of using interferon α-2b in combination with vitamins E and C in the treatment of urogenital infections in pregnant women
by: T. A. Ruzhentsova, et al.
Published: (2021-06-01)

Antioxidant Impact on Specific Antiviral Activity of Human Recombinant Interferon α-2b with Respect to Herpes simplex in Cell Culture
by: A. N. Vasilyev
Published: (2020-05-01)

Evaluation of the effectiveness of antiviral therapy for coronavirus infection (COVID-19) with the inclusion of recombinant interferon alpha-2b
by: A. V. Mordyk, et al.
Published: (2022-10-01)

Keratopathy in Patients with Adenoviral Keratoconjunctivitis: Evaluation of the Effectiveness of Modern Interferon Preparations
by: E. A. Drozdova, et al.
Published: (2023-04-01)

IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Effect of interferon on broilers' fecal microbiome composition
by: Inna Burakova, et al.
Published: (2025-04-01)

INTERFERONS AND EYE DISEASES
by: N. A. Kikhtenko, et al.
Published: (2019-06-01)

Antiviral Activity of Recombinant Interferon-a-2b in Combination with Certain Antioxidant
by: A. N. Vasilev, et al.
Published: (2020-05-01)

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)
by: T. M. Reshetnyak, et al.
Published: (2024-04-01)

Digitoflavone Ameliorates Acute Lung Injury via Disturbing the Formation of Functional Stimulator of Interferon Genes Signalosome
by: Jun-Jie Li, et al.
Published: (2025-04-01)

Special features of antiviral immunity in elderly patients
by: I. V. Mannanova, et al.
Published: (2025-04-01)

Interferon-Gamma: Treatment Horizons
by: A. A. Khryanin, et al.
Published: (2020-05-01)

Interferon-γ: biological function and application for study of cellular immune response
by: A. A. Lutckii, et al.
Published: (2016-02-01)

The use of essential drugs : reports /
by: WHO Expert Committee
Published: (1983)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data
by: T. A. Panafidina, et al.
Published: (2025-03-01)

Expression of interferon-stimulated genes in patients with rheumatoid arthritis on anti-B-cell therapy (preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-10-01)